Ad
NVO Quote Trading Chart Novo Nordisk A/S
Quote | Novo Nordisk A/S (NYSE:NVO)
| Last: | $108.61 |
|---|---|
| Change Percent: | 0.73% |
| Open: | $110.88 |
| Close: | $108.61 |
| High: | $111.1691 |
| Low: | $108.41 |
| Volume: | 3,641,017 |
| Last Trade Date Time: | 12/12/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
NVO Last Twenty Trading Days
| Last | Open | Close | High | Low | Volume | Date |
|---|---|---|---|---|---|---|
| $108.61 | $110.88 | $108.61 | $111.1691 | $108.41 | 3,641,017 | 12-12-2024 |
| $111.69 | $110.45 | $111.69 | $112.52 | $110.02 | 6,545,662 | 12-11-2024 |
| $109.19 | $111.55 | $109.19 | $111.55 | $108.7 | 4,621,729 | 12-10-2024 |
| $111.08 | $111.72 | $111.08 | $111.99 | $110.3 | 4,908,910 | 12-09-2024 |
| $110.77 | $109.93 | $110.77 | $111.3061 | $109.75 | 6,045,653 | 12-06-2024 |
| $108.82 | $108.62 | $108.82 | $109.3243 | $108.23 | 3,914,363 | 12-05-2024 |
| $108.97 | $110.22 | $108.97 | $110.52 | $108.96 | 4,485,590 | 12-04-2024 |
| $109.2 | $110.78 | $109.2 | $110.88 | $109.05 | 4,828,723 | 12-03-2024 |
| $108.67 | $108.93 | $108.67 | $109.14 | $108.15 | 4,948,303 | 12-02-2024 |
| $106.8 | $105.43 | $106.8 | $107.4 | $105.3485 | 2,775,149 | 11-29-2024 |
| $106.13 | $105.79 | $106.13 | $106.13 | $104.961 | 3,990,584 | 11-28-2024 |
| $106.13 | $105.79 | $106.13 | $106.13 | $104.961 | 3,990,584 | 11-27-2024 |
| $106.13 | $106.67 | $106.13 | $107.7 | $105.63 | 6,761,371 | 11-26-2024 |
| $104.56 | $105.31 | $104.56 | $105.92 | $104.0001 | 4,294,622 | 11-25-2024 |
| $105.06 | $103.91 | $105.06 | $106.24 | $103.86 | 6,143,345 | 11-22-2024 |
| $102.63 | $103.18 | $102.63 | $103.22 | $101.5113 | 6,185,447 | 11-21-2024 |
| $105.27 | $103.43 | $105.27 | $105.74 | $103 | 7,520,708 | 11-20-2024 |
| $102.63 | $101.18 | $102.63 | $103.12 | $101.14 | 5,778,724 | 11-19-2024 |
| $99.81 | $100.32 | $99.81 | $101 | $99.42 | 8,790,052 | 11-18-2024 |
| $101.74 | $101.67 | $101.74 | $102.34 | $100.32 | 8,076,248 | 11-15-2024 |
News, Short Squeeze, Breakout and More Instantly...
Ad
-
2024-12-13 05:03:00 ET Finding a good growth stock to buy these days isn't easy. Many that have been doing well are at sky-high valuations. Investing in a stock at a steep premium can limit the return you can earn from it, or worse, result in a significant loss in the event of slowing marke...
-
2024-12-10 04:10:00 ET One particular healthcare stock has shown its ability to soar on good news -- and it's had plenty of it. This year the company reported solid results from trials of a candidate meant to address one of today's hottest growth areas: weight loss. The weight loss drug mar...
-
2024-12-09 04:59:00 ET According to a sneak peek of the data from one of Eli Lilly 's (NYSE: LLY) late-stage clinical trials, the cardiometabolic medicine juggernaut now looks even stronger in comparison to its similarly powerful arch-rival, Novo Nordisk , (NYSE: NVO) and it...